Britannia Life Sciences Inc
CNSX:BLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Singer India Ltd
BSE:505729
|
IN |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
|
NSE SA
PAR:ALNSE
|
FR |
|
Daito Trust Construction Co Ltd
TSE:1878
|
JP |
|
Anhui Tongfeng Electronics Co Ltd
SSE:600237
|
CN |
|
Xencor Inc
NASDAQ:XNCR
|
US |
|
T
|
Troax Group AB (publ)
STO:TROAX
|
SE |
|
Next Mediaworks Ltd
NSE:NEXTMEDIA
|
IN |
|
S
|
Sonadezi Long Binh Share Holding Co
VN:SZB
|
VN |
|
Cizzle Biotechnology Holdings PLC
LSE:CIZ
|
UK |
Britannia Life Sciences Inc
Total Equity
Britannia Life Sciences Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc
CNSX:BLAB
|
Total Equity
CA$6.3m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Total Equity
CA$88.4m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Equity
CA$758.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
19%
|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Total Equity
CA$536.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
57%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Total Equity
CA$1.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Equity
$1.1B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
63%
|
|
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
See Also
What is Britannia Life Sciences Inc's Total Equity?
Total Equity
6.3m
CAD
Based on the financial report for Mar 31, 2025, Britannia Life Sciences Inc's Total Equity amounts to 6.3m CAD.
What is Britannia Life Sciences Inc's Total Equity growth rate?
Total Equity CAGR 3Y
67%
Over the last year, the Total Equity growth was 158%. The average annual Total Equity growth rates for Britannia Life Sciences Inc have been 67% over the past three years .
